Clinical Trials Logo

Clinical Trial Summary

This study evaluates the effect of the addition of ketamine to a conscious sedation protocol including remifentanil during oocyte retrieval. The investigators will have 2 groups with different target effect site concentrations, namely 150 ng/ml and 200 ng/ml.


Clinical Trial Description

The actual protocol for conscious sedation during oocyte retrieval in at the Erasmus hospital (Brussels) consists of Remifentanil in TCI-mode, with premedication by Midazolam. However, episodes of bradypnaea with or without desaturation are still common.

The primary objective is to observe if with the addition of ketamine, it is possible to significantly reduce the dose of Remifentanil, in order to avoid episodes of respiratory depression caused by the opioid.

The secondary outcomes measured, will be the pain levels experienced by the patient, the sedation level, and the satisfaction of the patients after the procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03458143
Study type Observational
Source Erasme University Hospital
Contact barvais luc, MD PhD
Phone +3225553919
Email luc.barvais@erasme.ulb.ac.be
Status Recruiting
Phase N/A
Start date February 12, 2018
Completion date March 31, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03472430 - Transcutaneous Electrical Nerve Stimulation During Transvaginal Oocyte Retrieval N/A
Completed NCT00995280 - Single Lumen Needle Without Flushing or Double Lumen Needle With Follicle Flushing in Oocyte Retrieval N/A
Completed NCT03105518 - Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction Phase 4